These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 25521115)

  • 1. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments.
    Vecchi Brumatti L; Marcuzzi A; Tricarico PM; Zanin V; Girardelli M; Bianco AM
    Molecules; 2014 Dec; 19(12):21127-53. PubMed ID: 25521115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease.
    Sreedhar R; Arumugam S; Thandavarayan RA; Karuppagounder V; Watanabe K
    Drug Discov Today; 2016 May; 21(5):843-9. PubMed ID: 26995272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin has bright prospects for the treatment of inflammatory bowel disease.
    Hanai H; Sugimoto K
    Curr Pharm Des; 2009; 15(18):2087-94. PubMed ID: 19519446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
    Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication.
    Ali T; Shakir F; Morton J
    Digestion; 2012; 85(4):249-55. PubMed ID: 22950087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?
    Mazieiro R; Frizon RR; Barbalho SM; Goulart RA
    J Med Food; 2018 Nov; 21(11):1077-1085. PubMed ID: 29957091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review.
    Simadibrata M; Halimkesuma CC; Suwita BM
    Acta Med Indones; 2017 Oct; 49(4):363-368. PubMed ID: 29348389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease.
    Beloqui A; Memvanga PB; Coco R; Reimondez-Troitiño S; Alhouayek M; Muccioli GG; Alonso MJ; Csaba N; de la Fuente M; Préat V
    Colloids Surf B Biointerfaces; 2016 Jul; 143():327-335. PubMed ID: 27022873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease.
    Epstein J; Docena G; MacDonald TT; Sanderson IR
    Br J Nutr; 2010 Mar; 103(6):824-32. PubMed ID: 19878610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin: a boon to colonic diseases.
    Sareen R; Jain N; Pandit V
    Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations.
    Baliga MS; Joseph N; Venkataranganna MV; Saxena A; Ponemone V; Fayad R
    Food Funct; 2012 Nov; 3(11):1109-17. PubMed ID: 22833299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease.
    Sardou HS; Vosough PR; Abbaspour M; Akhgari A; Sathyapalan T; Sahebkar A
    Inflammopharmacology; 2023 Jun; 31(3):1095-1105. PubMed ID: 36757584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials.
    Fallahi F; Borran S; Ashrafizadeh M; Zarrabi A; Pourhanifeh MH; Khaksary Mahabady M; Sahebkar A; Mirzaei H
    Mol Immunol; 2021 Feb; 130():20-30. PubMed ID: 33348246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Curcumin add-on therapy for ulcerative colitis].
    Salomon N; Lang A; Gamus D
    Harefuah; 2015 Jan; 154(1):56-8, 66. PubMed ID: 25796678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tolerability of treatments for inflammatory bowel disease.
    Stein RB; Hanauer SB
    Drug Saf; 2000 Nov; 23(5):429-48. PubMed ID: 11085348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New molecules in the treatment of inflammatory bowel disease].
    Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2016; 39(6):411-23. PubMed ID: 26631943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook.
    Karthikeyan A; Young KN; Moniruzzaman M; Beyene AM; Do K; Kalaiselvi S; Min T
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.